Lars Rasmussen

Lars Rasmussen leads Coloplast, a Danish medical device company with a unique origin story: it was founded in 1957 by Elise Sørensen, a nurse who invented the world's first adhesive ostomy bag to help her sister, who had undergone a colostomy. Today, Coloplast is a global leader in intimate healthcare — products that address conditions people rarely discuss publicly but that profoundly impact quality of life. Coloplast operates in four business areas: Ostomy Care (bags and accessories for people with stomas — approximately 45% of revenue), Continence Care (catheters and accessories for people with urinary retention or incontinence), Wound Care (advanced wound dressings for chronic wounds), and Interventional Urology (through the 2020 acquisition of Atos Medical, maker of Provox voice prostheses for laryngectomy patients). The acquisition of Atos Medical added a high-growth, high-margin business. The business model generates exceptionally recurring revenue: ostomy bags and catheters are consumables that patients use daily for life, creating long-term customer relationships. Coloplast's direct-to-patient relationship (through its care programs and home delivery services) further strengthens customer loyalty. Key stock drivers include organic revenue growth, emerging market penetration, Atos Medical integration and growth, pricing and reimbursement trends, innovation pipeline, operating margin expansion, and the aging population demographic tailwind.